ND4 COST-UTILITY OF INTERFERON BETA-1B IN THE TREATMENT OF PATIENTS WITH A CLINICALLY ISOLATED SYNDROME SUGGESTIVE OF MULTIPLE SCLEROSIS- MODEL UTILIZING FIVE YEAR BENEFIT DATA
May 1, 2009, 00:00
10.1016/S1098-3015(10)73129-6
https://www.valueinhealthjournal.com/article/S1098-3015(10)73129-6/fulltext
Title :
ND4 COST-UTILITY OF INTERFERON BETA-1B IN THE TREATMENT OF PATIENTS WITH A CLINICALLY ISOLATED SYNDROME SUGGESTIVE OF MULTIPLE SCLEROSIS- MODEL UTILIZING FIVE YEAR BENEFIT DATA
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)73129-6&doi=10.1016/S1098-3015(10)73129-6
First page :
Section Title :
Open access? :
No
Section Order :
226